Home › Funds › Citigroup Inc › CUE
Citigroup Inc position in CUE
CUE BIOPHARMA INC · Health Care
Latest position (Q2 2026)1 sh
Reported value held$32
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 28.20K | $411.00K | New |
| Q4 2021 | 80.19K | $907.00K | Add |
| Q1 2022 | 2.02K | $10.00K | Reduce |
| Q2 2022 | 312 | $1.00K | Reduce |
| Q2 2023 | 10.29K | $37.57K | New |
| Q3 2023 | 35 | $80 | Reduce |
| Q4 2023 | 5.59K | $14.75K | Add |
| Q1 2024 | 6.07K | $11.47K | Add |
| Q2 2024 | 5.04K | $6.26K | Reduce |
| Q3 2024 | 43 | $33 | Reduce |
| Q4 2024 | 43 | $47 | Hold |
| Q3 2025 | 132 | $95 | New |
| Q2 2026 | 1 | $32 | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CUE
- BlackRock Inc 57.81K sh · $1.82M · Q2 2026
- Geode Capital Management 47.82K sh · $1.51M · Q2 2026
- Vanguard Group 3.01M sh · $919.28K · Q4 2025
- UBS Group AG 26.70K sh · $842.65K · Q2 2026
- Citadel Advisors 25.63K sh · $808.98K · Q2 2026
- Renaissance Technologies 14.69K sh · $463.58K · Q2 2026
- Northern Trust Corp 9.12K sh · $287.89K · Q2 2026
- Bank of America Corp 6.93K sh · $218.68K · Q2 2026
- Morgan Stanley 674 sh · $21.27K · Q2 2026
- JPMorgan Chase & Co 163 sh · $4.96K · Q2 2026
- Wells Fargo & Co 26 sh · $821 · Q2 2026